secwatch.observer — SEC 8-K summary
======================================

Issuer:     Transcode Therapeutics, Inc. (RNAZ)
CIK:        0001829635
Form:       8-K
Filed at:   2025-10-03T23:59:59+00:00
Accession:  0001104659-25-096658
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01
LLM model:  deepseek-v4-flash:cloud@v2

TransCode Therapeutics amends MGH license; milestone payments doubled to $2.95M per patent family
--------------------------------------------------------------------------------

- Second Amendment to Exclusive Patent License Agreement with Massachusetts General Hospital, effective August 15, 2025.
- Updated timelines for pre-sales requirements for Patent Family 1 and Patent Family 2.
- Aggregate one-time milestone payments increased from $1.55M to $2.95M for each patent family.
- Individual milestone amounts for therapeutic product/process milestones also updated.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1829635/000110465925096658/0001104659-25-096658-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1829635/000110465925096658/tm2527978d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-096658

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer